MAPT and Alzheimer disease: Many of studies suggested that TREM2 participates in AD pathogenesis through intraneuronal deposition of phosphorylated tau besides Aβ1-42 deposition and clearance (Jay et al., 2015; Jiang et al., 2015, 2018).